
Rachael Grace MD
Associate Professor, Boston Children's Hospital
Join to View Full Profile
300 Longwood AveChildrens Hospital Boston Karp 8Boston, MA 02115
Phone+1 617-355-6000
Dr. Grace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2003 - 2006
- The Warren Alpert Medical School of Brown UniversityClass of 2003
Certifications & Licensure
- MA State Medical License 2006 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP Start of enrollment: 2013 Aug 01
- Pyruvate Kinase Deficiency Natural History Study Start of enrollment: 2013 Dec 01
- A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency Start of enrollment: 2015 Jun 26
- Join now to see all
Publications & Presentations
PubMed
- Critical Bleeding in Adults and Children with Immune Thrombocytopenia: A Multicenter Cohort Study.Emily Sirotich, Saifur R Chowdhury, Dimpy Modi, Gordon H Guyatt, Melanie St John
Blood Advances. 2025-04-09 - Correlation of Genetic Mutation With Outcomes in Children With Hereditary Spherocytosis Undergoing Partial Splenectomy: A Multicentre Study.Joshua K Ramjist, Tamara Dubljevic, Eveline Lapidus-Krol, Rachael F Grace, Matthew M Heeney
Journal of Pediatric Surgery. 2025-04-01 - 1 citationsWorking toward international consensus defining pediatric "refractory ITP".Candelaria O'Farrell, Amanda Bell Grimes, Taizo A Nakano, Robert J Klaassen, Michele P Lambert
Blood Advances. 2025-03-11
Abstracts/Posters
- Comorbidities and Complications in Adults with Pyruvate Kinase DeficiencyRachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in ChildrenRachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Effect of Pathway to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of DiagnosisRachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Special Education Session on ASH Clinical Practice Guidelines on Immune Thrombocytopenia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
- Mitapivat Produces Durable Hemoglobin Responses in Patients with Pyruvate Kinase DeficiencyDecember 11th, 2021
- More Than 110 Dana-Farber Affiliated Faculty Named as 2021 Top Doctors in Boston MagazineJanuary 5th, 2021
- Mitapivat Elicits Positive Response in Pyruvate Kinase DeficiencySeptember 4th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: